Clinical Application Guideline of Combination With Traditional Chinese Medicine and Western Medicine in the Prevention and Treatment of Chronic Obstructive Pulmonary Disease (2024)

Abstract

Aim: Chronic Obstructive Pulmonary Disease (COPD) is a common chronic airway disease that can lead to decreased lung function in patients. It places a heavy economic burden on patients and society. Traditional Chinese medicine (TCM) and Western medicine have played important roles in managing COPD. We aimed to develop an evidence-based guideline for treating COPD with Chinese and Western Medicine.

Methods: We formed a guideline panel of multidisciplinary experts. The clinical questions were identified based on two rounds of issue solicitation and expert demonstration. We searched the literature for direct evidence on the management of COPD and assessed its certainty-generated evidence using the grading of recommendations, assessment, development, and evaluation (GRADE) approach. The recommendations and their strengths were formulated using the Delphi method.

Results: Our guideline covers aspects of the diagnosis and treatment of COPD such as principles and commonly used medications for both traditional Chinese medicine and Western medicine, complications, and the high-risk populations. 9 clinical questions and 35 recommendations were identified, which covered the combinations of YuPingFeng granule, Buzhong Yiqi decoction, Gushen Dingchuan Pill, Bufei Huoxue Capsules, Runfei cream, Bailing Capsule, Tanyin Pills, etc., and nonpharmacological therapy of TCM such as combined acupoint application, electroacupuncture, and Chinese exercise techniques (Tai Chi, Baduanjin), etc. Recommendations were either high or low or in the form of ungraded consensus-based statements.

Conclusions: This is a comprehensive and systematic evidence-based guideline and we hope it can systematically and effectively guide clinicians in managing COPD and improve overall medical care.

Keywords

chronic obstructive pulmonary disease / evidence-based guideline / integrating Chinese and western medicine / recommendation / traditional Chinese medicine

References

[1] Global Strategy for Prevention, Diagnosis and Management of COPD, 2024, https://lgoldcopd.org/2024.gold-report/.

[2] C. Wang, J. Xu, L. Yang, et al., “Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease in China (the China Pulmonary Health [CPH] study): A National Cross-Sectional Study,” Lancet (London, England) 391, no. 10131 (2018): 1706-1717.

[3] W. Li, T. Yang, and C. Wang, “Current Status and Progress of Chronic Obstructive Pulmonary Disease Prevention and Treatment in China,” Chinese Research Hospitals 7, no. 5 (2020): 1-5.

[4] P. M. A. Calverley and P. P. Walker, “Contemporary Concise Review 2022: Chronic Obstructive Pulmonary Disease,” Respirology (Carlton, Vic.) 28, no. 5 (2023): 428-436.

[5] Collaborators GBDCoD. Global Burden of 288 Causes of Death and Life Expectancy Decomposition in 204 Countries and Territories and 811 Subnational Locations, 1990-2021: A Systematic Analysis for the Global Burden of Disease Study 2021. Lancet 2024; 403(10440): 2100-2132.

[6] Standardization Project Group of "Guidelines for Clinical Application of Traditional Chinese Medicines in Treating Advantageous Diseases," S. Zengtao, L. Jiangtao, and Z. Hongchun, “Clinical Application Guidelines of Chinese Patent Medicine for Chronic Obstructive Pulmonary Disease (2021),” Chinese Journal of Integrated Traditional And Western Medicine 2022; 42(8): 901-914.

[7] R. H. Brook, M. R. Chassin, A. Fink, D. H. Solomon, J. Kosecoff, and R. E. Park, “A Method for the Detailed Assessment of the Appropriateness of Medical Technologies,” International Journal of Technology Assessment in Health Care 2, no. 1 (1986): 53-63.

[8] R. Jaeschke, G. H. Guyatt, P. Dellinger, et al., “Use of GRADE Grid to Reach Decisions on Clinical Practice Guidelines When Consensus Is Elusive,” Bmj 337 (2008): a744.

[9] Y. Zhang, N. Liang, L. Yan, et al., “Methodology for the Development of Clinical PracticeGuidelines for Chinese Patent Medicine(Part 6):Formationand Presentation of Recommendation,” Journal of Traditional Chinese Medicine 65, no. 2 (2024): 172-178.

[10] Internal Medicine Committee of World Federation of Chinese Medicine Societies Chinese Medicine Societies, and L. Jiansheng, “Guideline of Integrated Chinese and Western Medicine for Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease,” Chinese Journal of Evidence-Based Medicine 2023; 23(10): 1117-1128.

[11] J. Li, “International Clinical Practice Guideline of Chinese Medicine Chronic Obstructive Pulmonary Disease,” World Journal of Traditional Chinese Medicine 15, no. 7 (2020): 1084-1092.

[12] China Association of Chinese Medicine. Diagnosis and Treatment Guideline for Chinese Medicine on Chronic Obstructive Pulmonary Disease (2019 edition). China Association of Chinese Medicine; 2019.

[13] Expert Consensus Writing Group of Integrated Traditional Chinese and Western Medicine Management for Chronic Obstructive Pulmonary Disease, Q. He and C. Feng, “Expert Consensus on Integrated Traditional Chinese and Western Medicine Management for Chronic Obstructive Pulmonary Disease (2023 Edition),” Chinese General Practice 26, no. 35 (2023): 4359-4371.

[14] M. K. Han, W. Ye, D. Wang, et al., “Bronchodilators in Tobacco-Exposed Persons With Symptoms and Preserved Lung Function,” New England Journal of Medicine 387, no. 13 (2022): 1173-1184.

[15] L. Qing, “The Effect of Yupingfeng Granule on Anxiety, Depression, and Lung Function in Patients With Stable Chronic Obstructive Pulmonary Disease,” Modern Journal of Integrated Traditional Chinese and Western Medicine 29, no. 23 (2020): 2566-2568.

[16] J. Ma, J. Zheng, N. Zhong, et al., “Effects of YuPingFeng Granules on Acute Exacerbations of COPD: A Randomized, Placebo-controlled Study,” Int J Chron Obstruct Pulmon Dis 13 (2018): 3107-3114.

[17] N. Ding, Y. Yuan, and R. Zhao, “Regulating Effect of Yupinfeng Powder on Exacerbation of COPD and Cellular Immune Imbalance,” Tianjin Journal of Traditional Chinese Medicine 39, no. 4 (2022): 443-449.

[18] H. Liu, D. Liang, J. Yu, Z. Zeng, and Y. Zhang, “Clinical Control Study of Buzhong Yiqi Decoction Combined With ICS/LABA/LAMA Triple Therapy in The Treatment of Stable COPD,” Journal of Guangdong Pharmaceutical University 37, no. 6 (2021): 129-133.

[19] L. Fan and H. Zhu, “Clinical Study on Buzhong Yiqi Decoction in the Treatment of Severe Stable Chronic Obstructive Pulmonary Disease,” Acta Chinese Medicine 31, no. 12 (2016): 1863-1866.

[20] K. Gui, J. Yang, Q. Long, and Y. Huang, “Efficacy of Gushen Dingchuan Pills and Western Medicine in Treating Stable Chronic Obstructive Pulmonary Disease Patients With Syndrome of Lung and Kidney Qi Deficiency,” Chinese Journal of Experimental Traditional Medical Formulae 25, no. 8 (2019): 89-94.

[21] X. Yang, H. Hu, S. Zhao, G. Yang, and B. Chen, “Effect of Gushen Dingchuan Pill on Pulmonary Function and Quality of Life in Patients of Stable Stage of Chronic Obstructive Pulmonary Disease,” Chinese Journal of Experimental Traditional Medical Formulae 19, no. 22 (2013): 283-286.

[22] J. Yang, “Regulating Effect of Gushen Dingchuan Pill on Stable Chronic Obstructive Pulmonary Disease,” Chinese Practical Journal of Rural Doctor 29, no. 3 (2022): 30-32.

[23] Z. Han, J. Wang, J. Han, and J. Lin, “A Systematic Review of Efficacy and Safety of Gushen Dingchuan Pills in the Treatment of Chronic Obstructive Pulmonary Disease,” Journal of Emergency in Traditional Chinese Medicine 30, no. 1 (2021): 32-36.

[24] J. Guo, L. Wu, Z. Tian, et al., “Observation on the Therapeutic Effect of Bufei Huoxue Capsule in Patients With Stable COPD,” Modern Journal of Integrated Traditional Chinese and Western Medicine 24, no. 4 (2015): 373-374.

[25] Y. Zhang, X. Xue, Y. Wu, et al., “Clinical Effect of Bufei Huoxue Capsules on Chronic Obstructive Pulmonary Disease Complicated With Pulmonary Arterial Hypertension and Its Effect on Tlymphocyte Subsets,” Chinese Traditional and Herbal Drugs 54, no. 21 (2023): 7111-7119.

[26] Y. Wang, Y. Shi, and X. Wang, “Efficacy of Yupingfeng San for Improving Lung Function and Quality of Life for Patients With Stable Chronic Obstructive Pulmonary Disease,” Evaluation and Analysis of Drug-Use in Hospitals of China 12, no. 9 (2012): 823-825.

[27] F. Zhang, Y. Liu, and S. Li, “Effects of Bailing Capsules Combined With Ipratropium Bromide Aerosol on Lung Function and Quality of Life of Patients With Chronic Obstructive Pulmonary Disease in Remission Stage,” Journal of Emergency in Traditional Chinese Medicine 19, no. 2 (2010): 198-209.

[28] X. Yuan, H. Li, and X. Gao, “Effect of Bailing Capsule on the Patients With Stable Chronic Obstructive Pulmonary Disease,” Journal of Xinxiang Medical College 35, no. 1 (2018): 42-49.

[29] C. Fan, Q. Miao, J. Fu, et al., “Huanglong Kechuan Capsule for Stable Chronic Obstructive Pulmonary Disease With Lung Kidney Qi Deficiency and Phlegm-Heat Constraint in the Lung Syndrome: A Multiple-Centered, Randomized, Placebo-Controlled, Double-Blind Trial of 160 Cases,” Journal of Traditional Chinese Medicine 62, no. 14 (2021): 1231-1237.

[30] H. Tan, J. Guan, and D. Liu, “Clinical Efficacy of Huanglongkechuan Capsule on Senilechronic Bronchitis,” Pharmacology and Clinics of Chinese Materia Medica 33, no. 5 (2017): 183-186.

[31] W. Xia, X. Mei, and X. Wang, “Clinical Observation of Bufei Huoxue Capsules Combined With Azithromycin Tablets in the Treatment of Patients With Stable COPD,” China Pharmacy 30, no. 10 (2019): 1403-1406.

[32] W. Liu, X. M. Liu, Y. L. Huang, et al., “Tai Chi as a Complementary Exercise for Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease: A Randomised Controlled Trial,” Complementary Therapies in Medicine 78 (2023): 102977.

[33] X. Chi, X. Zhang, H. Jiang, J. Wang, G. Zhang, and Q. Li, “Effects of Tai Chi on Acute Exacerbations of Patients With Moderate to Severe COPD in Stable Period,” Geriatrics Reserach 2, no. 4 (2021): 5-8.

[34] F. Chi, X. Ge, H. Xiao, J. Xu, Y. Fu, and C. Bai, “Influence of Baduanjin and Aerobic Training on Pulmonaryrehabilitation and Immune Function in Patients With Stablechronic Obstructive Pulmonary Diseases,” Guangdong Medical Journal 43, no. 12 (2022): 1518-1522.

[35] G. Xue, C. Feng, X. Yao, Y. Qi, Y. Wang, and J. Ma, “Efficacy of Fitness qigong Ba Duan Jin in Pulmonary Rehabilitation of Patients With Chronic Obstructive Pulmonary Disease at Stable Stage,” Journal of Beijing University of Traditional Chinese Medicine 38, no. 2 (2015): 139-144.

[36] G. Li, L. Wang, Y. Lin, et al., “Randomized Controlled Trial of Xiaochuangao Acupoint Paste to Treat Chronic Obstructive Pulmonary Disease in the Stable Phase: Treating Winter Diseases in Summer,” Chinese Journal of Integrated Traditional and Western Medicine 31, no. 9 (2011): 1187-1190.

[37] L. Dai, X. Chen, Y. Cai, X. Gao, K. Di, and Y. Hu, “Observations on the Efficacy of Winter Disease and Summer Treatment Acupoint Application Method for the Treatment of Chronic Obstructive Pulmonary Disease in the Stable Stage,” People's Military Surgeon 59, no. 10 (2016): 1038-1046.

[38] B. Yu, H. Hu, M. Sun, Z. Zhu, and L. Xuan, “Randomized Controlled Study on the Treatment of Chronic Obstructive Pulmonary Disease With Cold Phlegm Blocking Pulmonary Type by Acupoint Plaster of Summer Treatment for Winter Disease,” China Journal of Traditional Chinese Medicine and Pharmacy 34, no. 8 (2019): 3818-3820.

[39] S. Yang, Y. Su, and Y. Huang, “The Effect of Shexiang Xiaochuan Ointment Acupoint Application Based on the Theory of ‘Summer Treatment on Quality of Life of Patients With for Winter Diseases’ Chronic Obstructive Pulmonary Disease in Stable Stage,” Clinical Journal of Chinese Medicine 15, no. 12 (2023): 46-50.

[40] M. Wang, Y. Xie, Y. Shi, et al., “Effect of Moxibustion for Benefiting the Lung on Quality of Life and Efficacy Satisfaction of Stable Chronic Obstructive Pulmonary Disease Patients: A Multi-Center, Randomized Control Study,” Journal of Traditional Chinese Medicine 60, no. 14 (2019): 1202-1208.

[41] X. Lin, M. Wang, and J. Yang, “Literature Evaluation and Meta-analysis of Clinical Effect of Lung Benefiting Moxibustion on Chronic Obstructive Pulmonary Disease,” Chinese Journal of Gerontology 43, no. 12 (2023): 2865-2871.

[42] Y. Wu, Q. Mu, H. Wang, Y. Wang, Y. Zhao, and N. Wang, “Effect of Budesonide Formoterol Combined With Sanfu Paste on Lung Function and TCM Symptoms of Patients With Chronic Obstructive Pulmonary Disease in Stable Stage,” Journal of Hubei University of Chinese Medicine 24, no. 1 (2022): 112-114.

[43] Z. Shi, T. Ni, and X. Wang, “Clinical Study on Warming-Needle Moxibustion Combined With Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation for COPD in Stable Stage,” Journal of New Chinese Medicine 53, no. 14 (2021): 150-153.

[44] T. Yang, M. Li, C. Ren, et al., “Evaluation of the Effects of Shufeng Jiedu Capsule on Inflammatory Factors and Safety in Patients With AECOPD,” Journal of Emergency in Traditional Chinese Medicine 28, no. 10 (2019): 1824-1827.

[45] J. Yang, X. Li, J. Wang, et al., “Efficacy and Safety of Shufeng Jiedu Capsules in theAdjuvant Treatment of Community-Acquired Pneumoniain Adult: A Meta-Analysis,” Chinese General Practice 25, no. 23 (2022): 2922-2931.

[46] B. Zhang, The 13th Five-Year Plan Teaching Material for the National Health and Family Planning Commission: Internal Medicine of Traditional Chinese Medicine. Third Edition (Beijing: People's Medical Publishing House, 2020).

[47] D. Chen, “Clinical Efficacy of cefuroxime Sodium Combined With Tanreqing Injection in the Treatment of Patients With COPD Complicated With Lung Infection,” Strait Pharmaceutical Journal 27, no. 12 (2015): 136-137.

[48] Y. Jiang, S. Ni, X. Zhang, et al., “Meta-Analysis and Trial Sequential Analysis of Tanreqing Injection in Treatment of Severe Pneumonia in Elderly,” China Journal of Chinese Materia Medica 49, no. 4 (2024): 1091-1101.

[49] Y. Liao, K. Wang, J. Qin, et al., “A Multicenter and Prospective Study on the Treatment of Acute Exacerbation of Mild to Moderate COPD With Danlong Oral Liquid,” Chinese Journal of Lung Disease (Electronic Edition) 16, no. 3 (2023): 306-311.

[50] R. Feng, Y. Zhang, and Z. Lin, “Clinical Study of Guilong Kechuanning Capsules Combined With Fidostatin in Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease,” Drugs & Clinic 35, no. 3 (2020): 497-502.

[51] Y. Feng, H. Huo, and Q. Tang, “Clinical Study of Qingfei Xiaoyan Pills Combined With Salbutamol in Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease,” Drugs & Clinic 36, no. 12 (2021): 2546-2551.

[52] S. Ren, F. Fan, J. Xiao, et al., “Clinical Study on Qingke Pingchuan Granules in Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease With Phlegm-Heat Obstructing Lung Syndrome,” Chinese Traditional and Herbal Drugs 54, no. 19 (2023): 6377-6385.

[53] T. Li, X. Zhang, M. Xu, L. Shao, and K. Liu, “Effects of Qingjin Huatan Decoction in Treating Acute Exacerbation of Chronic Obstructive Pulmonary Diseaseon the Clinical Efficacy, Inflammatory Response and Airway Mucus Hyper Secretion,” Clinical Journal of Traditional Chinese Medicine 32, no. 4 (2020): 781-786.

[54] G. Li, G. Xu, L.i j, M. Zhao, and Q. Deng, “Clinical Effect of Qingjin Huatan Decoction Combined With Western Medicine on Acute Exacerbation of Chronic Obstructive Pulmonary Disease,” China Medicine 13, no. 7 (2018): 1012-1016.

[55] G. Li, X. Sun, Y. Deng, J. Lai, and Q. Liu, “Meta-Analysis and Trial Sequential Analysis of QingjinHuatan Decoction for Treating Community-Acquired Pneumonia in Elderly,” China Journal of Chinese Materia Medica 45, no. 11 (2020): 2658-2667.

[56] W. Yang, L. Zou, Z. Deng, Y. Li, and Y. Li, “Analysis of the Effect of Tanreqing Injection as Adjunctive Therapy in 120 Elderly Patients With AECOPD,” Guangxi Medical Journal 36, no. 12 (2014): 1804-1805.

[57] H. Chen, Z. Deng, and Y. Wen, “Therapeutic Effect of Tanreging in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Clinical Observation,” Journal of Emergency in Traditional Chinese Medicine 25, no. 2 (2016): 300-302.

[58] Y. Gai, Y. Hao, and X. Li, “Discussion on Effect of Tanreging Injection on Pulmonary Function and Protective Mechanism in Elderly Patients With Chronic Obstructive Pulmonary Disease and Respiratory Failure,” Liaoning Journal Of Traditional Chinese Medicine 45, no. 1 (2018): 69-72.

[59] J. Ding and N. Gao, “The Effect of Tanreqing Injection on Patients With COPD Who Have Difficulty Weaning From Mechanical Ventilation,” Shaanxi Journal of Traditional Chinese Medicine 36, no. 10 (2015): 1326-1327.

[60] M. Chen, W. Qian, X. Xuan, Y. Xu, and L. Chen, “Clinical Study of Noninvasive Positive Pressure Ventilation Combined With Tanreging Injection for Acute Exacerbation of Chronic Obstructive Pulmonary Disease Complicated With Respiratory Failure,” Journal of Emergency in Traditional Chinese Medicine 31, no. 4 (2022): 648-650.

[61] X. Wang, H. Zhang, H. Tian, C. Wang, and K. Wang, “Shenfu Injection Combined With Mechanical Ventilation for 30 Cases of Acute Exacerbation of Chronic Obstructive Pulmonary Disease,” Journal of Traditional Chinese Medicine 54, no. 16 (2013): 1386-1389.

[62] W. Liu, F. Wu, and S. Yu, “Observation of Curative Effect of Acute Exacerbation Chronic Obstructive Pulmonary Disease and Type Irespiratory Failure Mechanical Ventilation Treated by Shenmai Injection,” Hebei Journal of Traditional Chinese Medicine 35, no. 2 (2013): 264-266.

[63] X. Li, “Observation on the Therapeutic Effect of Shenmai Injection as an Adjuvant Therapy for Mechanical Ventilation in Patients With AECOPD Complicated With Type II Respiratory Failure,” Journal of New Chinese Medicine 47, no. 10 (2015): 46-47.

[64] C. Zheng, J. Wei, Y. Wang, et al., “Meta-analysis of Efficacy and Safety of Shen Mai Injection Combined With Western Medicine in the Treatment of Pulmonary Heart Disease,” Traditional Chinese Drug Research and Clinical Pharmacology 32, no. 2 (2021): 287-294.

[65] L. Lian, Z. Jiang, and J. Huang, “A Clinical Study of Jia Wei Liang Ge Powder and Western Medicine Treatment of 60 Cases of Acute Exacerbation of COPD,” Jiangsu Journal of Traditional Chinese Medicine 52, no. 6 (2020): 28-31.

[66] X. Hu, Y. Li, H. Li, and N. Li, “Electroacupuncture for Acute Exacerbation of Chronic Obstructive Pulmonary Disease Complicated withg Astrointestinal Dysfunction: A Randomized Controlled Tria,” Chinese Acupuncture and Moxibustion 43, no. 5 (2023): 499-503.

RIGHTS & PERMISSIONS

2025 The Author(s). Journal of Evidence-Based Medicine published by Chinese Cochrane Center, West China Hospital of Sichuan University and John Wiley & Sons Australia, Ltd.